Compounds > n 0861
Page last updated: 2024-09-03

n 0861 and Pain

n 0861 has been researched along with Pain in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belardinelli, L; Bertolet, BD; Franco, EA; Hill, JA; Kerensky, RA; Nichols, WW1
Barrett, RJ1

Reviews

1 review(s) available for n 0861 and Pain

ArticleYear
Realizing the potential of adenosine-receptor-based therapeutics.
    Proceedings of the Western Pharmacology Society, 1996, Volume: 39

    Topics: Adenine; Animals; Clinical Trials as Topic; Humans; Norbornanes; Pain; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrazoles; Pyridines; Receptors, Purinergic P1; Renal Insufficiency; Theophylline

1996

Other Studies

1 other study(ies) available for n 0861 and Pain

ArticleYear
Selective attenuation by N-0861 (N6-endonorboran-2-yl-9-methyladenine) of cardiac A1 adenosine receptor-mediated effects in humans.
    Circulation, 1996, May-15, Volume: 93, Issue:10

    Topics: Adenine; Adenosine; Aged; Coronary Circulation; Dose-Response Relationship, Drug; Female; Heart; Humans; Male; Middle Aged; Norbornanes; Pain; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1

1996